Related Experiment Videos
Treatment of advanced breast cancer: How much chemotherapy is enough?
R S DiPaola1, A Kaufman, M M Mikhail
1The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, New Brunswick, USA.
Seminars in Oncology
|June 1, 1996
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Ten-year survival rates by PSA nadir in patients with metastatic hormone-sensitive prostate cancer: long-term survival analysis from the ECOG-ACRIN 3805 (CHAARTED) trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
Two novel pathogenic variants in MED13L: one familial and one isolated case.
Journal of intellectual disability research : JIDR·2021
Deliberating performance targets workshop: Potential paths for emerging PM2.5 and O3 air sensor progress.
Atmospheric Environment: X·2021
Baseline brain function in the preadolescents of the ABCD Study.
Nature neuroscience·2021
Deliberating Performance Targets: Follow-on workshop discussing PM10, NO2, CO, and SO2 air sensor targets.
Atmospheric environment (Oxford, England : 1994)·2021
Rhabdomyolysis resulting from the interaction of rosuvastatin and abiraterone: A case study.
Seminars in oncology·2026
NK3 subsets are linked to NK cell exhaustion and immunotherapy responsiveness in tumor.
Seminars in oncology·2026
Dual alexithymia: A relational framework for clinical communication in oncology.
Seminars in oncology·2026
SPIB as a context-specific regulator in cancer: from molecular mechanisms to clinical implications.
Seminars in oncology·2026
The role of fumarate and itaconate in tumor microenvironment.
Seminars in oncology·2026
Management of ectopic Cushing syndrome in medullary thyroid carcinoma: from case reports to systematic literature review.
Frontiers in endocrinology·2026
Catatonic Features That May Be Mistaken for Worsening Autism Show Treatment-Associated Improvement: Implications for Later Regression.
medRxiv : the preprint server for health sciences·2026
Integrative pipeline to profile and target endocrine therapy-insensitive cell populations in ER+ breast cancer.
bioRxiv : the preprint server for biology·2026